Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants With Major Depressive Disorder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06793397
Title field or adapter rule
{'original_value': 'An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants With Major Depressive Disorder', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:37.217455+00:00
Published At
2026-10-30T00:00:00+00:00
Record Updated At
2026-10-30
Source Retrieved At
2026-10-31T22:19:07.580396+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Major Depressive Disorder (MDD)", "Depression in Adults", "Depression - Major Depressive Disorder", "Depression Disorders", "Depression Disorder", "Depression"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-30", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06793397"
protocolSection.identificationModule.officialTitle
"An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants With Major Depressive Disorder"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Major Depressive Disorder (MDD) (protocolSection.conditionsModule.conditions)
  • Depression in Adults (protocolSection.conditionsModule.conditions)
  • Depression - Major Depressive Disorder (protocolSection.conditionsModule.conditions)
  • Depression Disorders (protocolSection.conditionsModule.conditions)
  • Depression Disorder (protocolSection.conditionsModule.conditions)
  • Depression (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Experimental Arm A CYB003 in 2 of 2 Dosing Sessions', 'Experimental Arm B CYB003 in 2 of 2 Dosing Sessions'], 'description': 'CYB003 is a deuterated psilocin analog.', 'name': 'CYB003', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Experimental Arm A CYB003 in 2 of 2 Dosing Sessions', 'Experimental Arm B CYB003 in 2 of 2 Dosing Sessions', 'Placebo Comparator: Arm C Placebo in 2 of 2 Dosing Session'], 'description': 'Manualized psychological support performed by facilitator.', 'name': 'Psychological Support', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • CYB003 (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.